Clinical Trial Update: Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED) [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating whether low-dose PegIntron promotes ALT normalization in Japanese patients with chronic hepatitis C. The update summarizes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepatitis C | Phase 2 | Status: COMPLETED